Disease Association

Alliance Urges Joint Approach To AIDS And Tuberculosis

Published in Medical Letter on the CDC and FDA, December 23rd, 2001

Fighting the converging epidemics of HIV/AIDS and tuberculosis (TB) will require improved anti-TB drugs as well as wide access to antiretrovirals, with an integrated approach to treating both diseases, according to the Global Alliance for TB Drug Development, a public-private partnership created to develop new, affordable drugs to treat tuberculosis.

TB is the leading killer of AIDS patients, especially in hardest-hit Africa and Asia and over 12 million people are with both diseases among the 40 million living with HIV infection. Since effective treatment of TB in immunocompromised patients has been shown to extend their lives, improved TB drugs that simplify access...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2001-12-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry